Alterations in gut microbiota impact the pathophysiology of several diseases, including cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts potent immune modulat
This study investigates the prognostic value of the nutrition-immunity axis in postoperative non-small cell lung cancer (NSCLC) and explores the role of gut microbiota-derived metabolites in modulatin
Gut dysbiosis has been implicated in the pathophysiology of a growing number of non-communicable diseases. High through-put sequencing technologies and short chain fatty acid (SCFA) profiling enables
